2022 | Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
| CANCER DISCOVERY |
2011 | Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer | SUPPORTIVE CARE IN CANCER |
2009 | Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2000 | Effect of telomere and telomerase interactive agents on human tumor and normal cell lines
| Clinical Cancer Research |
1999 | Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector | ONCOLOGY REPORTS |
2010 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
2013 | Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2022 | Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial | JOURNAL OF CLINICAL ONCOLOGY |
2023 | Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial | INTERNATIONAL JOURNAL OF CANCER |
2022 | Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052 | ANNALS OF ONCOLOGY |
2018 | Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) | GASTRIC CANCER |
2016 | Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08
| CANCER RESEARCH AND TREATMENT |
2014 | Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency | EUROPEAN JOURNAL OF CANCER |
2011 | Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis | ONCOLOGY |
2015 | Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
| BMC CANCER |
2001 | Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities
| CANCER RESEARCH AND TREATMENT |
2012 | EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI
| YONSEI MEDICAL JOURNAL |
2022 | Enhanced supportive care for advanced cancer patients: study protocol for a randomized controlled trial
| BMC NURSING |
2007 | Entropy-based analysis of the non-linear relationship between gene expression profiles of amplified and non-amplified RNA | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
2019 | EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
| BMC CANCER |
2022 | Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
| GUT |
2012 | Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group | JOURNAL OF CLINICAL ONCOLOGY |
2016 | Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity
| NATURE COMMUNICATIONS |
2017 | Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma | CANCER DISCOVERY |
2016 | Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells
| ONCOTARGET |
2016 | Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial | LANCET |
2013 | Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study | JOURNAL OF SURGICAL ONCOLOGY |
2013 | Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
| BRITISH JOURNAL OF CANCER |
2012 | Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes | NATURE GENETICS |
2013 | External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study | LANCET ONCOLOGY |
2012 | External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer
| ANNALS OF ONCOLOGY |
2004 | Fabrication of high quality cDNA microarray using a small amount of cDNA | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
2022 | Fear of cancer recurrence and its predictors and outcomes among cancer survivors: A descriptive correlational study | EUROPEAN JOURNAL OF ONCOLOGY NURSING |
2013 | Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer | JOURNAL OF CLINICAL ONCOLOGY |
2016 | Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
| YONSEI MEDICAL JOURNAL |
2017 | Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
| ANNALS OF ONCOLOGY |
2014 | First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.
| BRITISH JOURNAL OF CANCER |
2024 | First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine Against HER2-Positive Advanced Gastric Cancer
| CANCER RESEARCH AND TREATMENT |
2022 | First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors
| INVESTIGATIONAL NEW DRUGS |
2014 | First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database Consortium.
| CLINICAL GENITOURINARY CANCER |
2016 | Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference | GASTRIC CANCER |
2018 | Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor | INTERNATIONAL JOURNAL OF CANCER |
2018 | Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
| KIDNEY CANCER(Kidney Cancer) |
2009 | G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern | CANCER LETTERS |
2011 | Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases | INVESTIGATIVE RADIOLOGY |
2016 | Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms | SUPPORTIVE CARE IN CANCER |
2007 | Gastrointestinal stromal tumor of the rectum: An analysis of seven cases | SURGERY TODAY |
2005 | Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
2005 | Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients
| CLINICAL CANCER RESEARCH |
2020 | Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells
| FRONTIERS IN ONCOLOGY |
2018 | Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
| CANCER RESEARCH AND TREATMENT |
2016 | Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites
| ONCOTARGET |
2003 | Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray | INTERNATIONAL JOURNAL OF ONCOLOGY |
2007 | Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization
| BMC GENOMICS |
2011 | Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis. | ONCOLOGY REPORTS |
2011 | Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.
| CLINICAL CANCER RESEARCH |
2022 | Genomic profiling as a response predictor of second-line treatment in advanced gastric cancer patients: Post-hoc analyses of two phase Ib/II trials | JOURNAL OF CLINICAL ONCOLOGY |
2010 | Green tea consumption and stomach cancer risk: a meta-analysis
| EPIDEMIOLOGY AND HEALTH |
2004 | Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines | CANCER LETTERS |
2021 | Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea
| CANCER RESEARCH AND TREATMENT |